|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_on1350617013 |
003 |
OCoLC |
005 |
20231120010710.0 |
006 |
m o d |
007 |
cr un|---aucuu |
008 |
221111s2022 mau o 000 0 eng d |
040 |
|
|
|a YDX
|b eng
|c YDX
|d OPELS
|d BXM
|d SFB
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1350605001
|
020 |
|
|
|a 9780323997898
|q (electronic bk.)
|
020 |
|
|
|a 0323997899
|q (electronic bk.)
|
020 |
|
|
|z 9780323997881
|
020 |
|
|
|z 0323997880
|
035 |
|
|
|a (OCoLC)1350617013
|z (OCoLC)1350605001
|
050 |
|
4 |
|a QH603.I54
|
082 |
0 |
4 |
|a 571.64
|2 23
|
245 |
0 |
0 |
|a Ion transport and membrane interactions in vascular health and disease /
|c Edited by Michael Sturek.
|
260 |
|
|
|a Cambridge, MA :
|b Academic Press,
|c 2022.
|
300 |
|
|
|a 1 online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Current topics in membranes ;
|v v. 90
|
588 |
0 |
|
|a Print version record.
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
|
|a Intro -- Ion Transport and Membrane Interactions in Vascular Health and Disease -- Copyright -- Contents -- Contributors -- Preface -- Acknowledgments -- Chapter One: Introduction to ion transport and membrane interactions in vascular health and disease -- 1. Vascular specificity in health and disease -- 2. Metabolic disease milieu and experimental approaches and models -- 3. Snapshot of ion transport and membrane interactions -- 4. Conclusions and future directions -- Acknowledgments -- References -- Chapter Two: An unexpected effect of risperidone reveals a nonlinear relationship between cytosolic Ca uptake -- 1. Introduction -- 2. Materials and methods -- 2.1. Materials and compounds -- 2.2. Cell culture and preparation -- 2.3. Transfection -- 2.4. Buffers and solutions -- 2.5. Loading with fura-2/am -- 2.6. Genetically-encoded fluorescent sensors -- 2.7. Microscopes and acquisition -- 2.8. Data analysis -- 2.9. Statistics -- 3. Results -- 3.1. Risperidone inhibited cytosolic Ca transients -- 3.2. The effect of risperidone on endothelial Ca was exclusively due to its inhibitory effect on histamine-triggered sign ... -- 3.3. Risperidone inhibited histamine-induced mitochondrial Ca signals -- 3.4. Risperidone appears more potent in preventing histamine-induced mitochondrial Ca elevations -- 3.5. Using various concentrations of risperidone, a linear cytosolic Ca elevation upon histamine was achieved -- 3.6. The correlation between cytosolic and mitochondrial Ca elevations is biphasic but linear after a certain threshold -- 4. Discussion -- Conflict of interest -- Acknowledgments -- Author contributions -- References -- Chapter Three: Regulation of exosome release by lysosomal acid ceramidase in coronary arterial endothelial cells: Role of ... -- 1. Introduction -- 2. Materials and methods.
|
505 |
8 |
|
|a 2.1. Isolation and culture of CAECs from mouse coronary artery -- 2.2. GCaMP3 Ca imaging -- 2.3. Isolation of lysosomes from CAECs -- 2.4. Whole-lysosome patch clamp recording -- 2.5. Structured illumination microscopy -- 2.6. Nanoparticle tracking analysis -- 2.7. Dynamic analysis of lysosome movement in CAECs -- 2.8. Statistical analysis -- 3. Results -- 3.1. Elevation of exosome release and reduction of lysosome-MVB interaction in CAECs lacking Asah1 gene -- 3.2. Inhibition of exosome release from CAECs lacking Asah1 gene by sphingosine -- 3.3. Regulation of lysosome trafficking and lysosome-MVB interaction by ML-SA1 and sphingosine in CAECs -- 3.4. Characterization of TRPML channels in CAECs -- 3.5. Blockade of TRPML1 channel by Asah1 gene deletion in CAECs -- 3.6. Rescue of TRPML1 channel activity by sphingosine in CAECs lacking Asah1 gene -- 3.7. Contribution of dynein activity to lysosomal regulation of exosome release in CAECs -- 4. Discussion -- References -- Chapter Four: Vascular CaV1.2 channels in diabetes -- 1. Introduction -- 2. General L-type Ca channel CaV1.2 structure -- 3. Regulation of vascular CaV1.2 channels -- 3.1. Splice variants -- 3.2. Phosphorylation -- 4. Effects of hyperglycemia on CaV1.2 -- 5. Mechanisms of hyperglycemia-induced regulation of vascular CaV1.2 channels -- 5.1. PKA -- 5.2. AC5 -- 5.3. P2Y11 -- 5.4. A-kinase anchoring proteins (AKAPs) -- 6. Conclusions and future directions -- Acknowledgments -- References -- Chapter Five: Multiphasic changes in smooth muscle Ca transporters during the progression of coronary atherosclerosis -- 1. Overview of vascular smooth muscle intracellular Ca regulation in health -- 2. Smooth muscle phenotypic modulation and [Ca]i handling alterations -- 3. Metabolic syndrome ``milieu�� -- 4. Atherogenesis.
|
505 |
8 |
|
|a 5. Function/dysfunction of Ca transporters during coronary atherosclerosis progression in swine -- 6. SERCA stimulation induces coronary smooth muscle proliferation in early atherosclerosis -- 6.1. Methods -- 6.1.1. Organ culture of epicardial conduit coronary arteries -- 6.1.2. Proliferation assay -- 6.1.3. Immunohistochemistry -- 6.1.4. Statistical analysis -- 6.2. Results -- 7. Similarity of swine and human coronary atherosclerosis and smooth muscle Ca signaling -- 8. Multiphasic model of coronary smooth muscle Ca transporter regulation in atherosclerosis -- 9. Conclusions and future directions -- Acknowledgments -- References -- Chapter Six: Specificity of Ca channel modulation in atherosclerosis and aerobic exercise training -- 1. General information on main types of K channels -- 1.1. Voltage-gated K channels (Kv) -- 1.2. ATP-sensitive K channels (KATP) -- 1.3. Inward rectifier K channels (Kir) -- 1.4. Calcium-activated K channels (BKCa) -- 2. Physiological roles of KCa channels -- 3. Effects of chronic exercise on reduction of cardiovascular disease and underlying K channel adaptations -- 4. Conclusions and future directions -- Acknowledgments -- References -- Chapter Seven: K+ channels in the coronary microvasculature of the ischemic heart -- 1. Introduction -- 2. Porcine model of ischemic heart disease -- 3. Role of K channels in basal active tone of arterioles from ischemic myocardium -- 4. Kv channels in arteriolar smooth muscle cells of ischemic myocardium -- 5. BKCa channels in arteriolar smooth muscle cells of ischemic myocardium -- 6. Role of additional K channel subfamilies in control of basal tone and vasodilation -- 7. Conclusion -- References.
|
650 |
|
0 |
|a Ion channels.
|
650 |
|
0 |
|a Membranes (Biology)
|
650 |
|
6 |
|a Canaux ioniques.
|0 (CaQQLa)201-0145111
|
650 |
|
6 |
|a Membranes (Biologie)
|0 (CaQQLa)201-0009733
|
650 |
|
7 |
|a Ion channels
|2 fast
|0 (OCoLC)fst00978573
|
650 |
|
7 |
|a Membranes (Biology)
|2 fast
|0 (OCoLC)fst01015860
|
700 |
1 |
|
|a Sturek, Michael,
|e editor.
|
776 |
0 |
8 |
|i ebook version :
|z 9780323997898
|
776 |
0 |
8 |
|c Original
|z 0323997880
|z 9780323997881
|w (OCoLC)1318990414
|
776 |
0 |
8 |
|i Print version:
|t ION TRANSPORT AND MEMBRANE INTERACTIONS IN VASCULAR HEALTH AND DISEASE.
|d [S.l.] : ELSEVIER ACADEMIC PRESS, 2022
|z 0323997880
|w (OCoLC)1318990414
|
830 |
|
0 |
|a Current topics in membranes ;
|v v. 90.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/10635823/90
|z Texto completo
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/bookseries/current-topics-in-membranes/vol/90/suppl/C
|z Texto completo
|